204 related articles for article (PubMed ID: 1442320)
1. Intravenous immunoglobulin in the prevention and treatment of neonatal bacterial sepsis.
Lassiter HA
Adv Pediatr; 1992; 39():71-99. PubMed ID: 1442320
[TBL] [Abstract][Full Text] [Related]
2. Use of intravenous immune globulin in newborn infants.
Fischer GW
Clin Exp Immunol; 1994 Jul; 97 Suppl 1(Suppl 1):73-7. PubMed ID: 8033439
[TBL] [Abstract][Full Text] [Related]
3. Therapeutic intervention of clinical sepsis with intravenous immunoglobulin, white blood cells and antibiotics.
Fischer GW; Weisman LE
Scand J Infect Dis Suppl; 1990; 73():17-21. PubMed ID: 2128662
[TBL] [Abstract][Full Text] [Related]
4. Multicenter randomized placebo controlled trial of therapy with intravenous immunoglobulin in decreasing mortality due to neonatal sepsis.
Shenoi A; Nagesh NK; Maiya PP; Bhat SR; Subba Rao SD
Indian Pediatr; 1999 Nov; 36(11):1113-8. PubMed ID: 10745332
[TBL] [Abstract][Full Text] [Related]
5. Polyclonal intravenous immunoglobulin for the treatment of severe sepsis and septic shock in critically ill adults: a systematic review and meta-analysis.
Laupland KB; Kirkpatrick AW; Delaney A
Crit Care Med; 2007 Dec; 35(12):2686-92. PubMed ID: 18074465
[TBL] [Abstract][Full Text] [Related]
6. Complement C3 deposition onto bacteria by neonatal serum is not enhanced after the infusion of intravenous immunoglobulin.
Lassiter HA; Speranza MJ; Hall RT; Meade V; Christensen RD; Parker CJ
J Perinatol; 1990 Mar; 10(1):27-31. PubMed ID: 2107285
[TBL] [Abstract][Full Text] [Related]
7. Intravenous polyclonal IgM-enriched immunoglobulin therapy in sepsis: a review of clinical efficacy in relation to microbiological aetiology and severity of sepsis.
Norrby-Teglund A; Haque KN; Hammarström L
J Intern Med; 2006 Dec; 260(6):509-16. PubMed ID: 17116001
[TBL] [Abstract][Full Text] [Related]
8. Post-marketing observational study on 5% intravenous immunoglobulin therapy in patients with secondary immunodeficiency and recurrent serious bacterial infections.
Günther G; Dreger B
Microbiol Immunol; 2013 Jul; 57(7):527-35. PubMed ID: 23607863
[TBL] [Abstract][Full Text] [Related]
9. Human intravenous immunoglobulin for experimental streptococcal toxic shock: bacterial clearance and modulation of inflammation.
Sriskandan S; Ferguson M; Elliot V; Faulkner L; Cohen J
J Antimicrob Chemother; 2006 Jul; 58(1):117-24. PubMed ID: 16670109
[TBL] [Abstract][Full Text] [Related]
10. Prenatal and postnatal prophylaxis of infections in preterm neonates.
von Muralt G; Sidiropoulos D
Pediatr Infect Dis J; 1988 May; 7(5 Suppl):S72-8. PubMed ID: 3135529
[TBL] [Abstract][Full Text] [Related]
11. [Current developments in the use of intravenous immunoglobulins].
Bardare M; Dellepiane RM
Minerva Pediatr; 1991 Nov; 43(11):665-74. PubMed ID: 1791793
[TBL] [Abstract][Full Text] [Related]
12. Clinical experience with polyclonal IgM-enriched immunoglobulins in a group of patients affected by sepsis after cardiac surgery.
Buda S; Riefolo A; Biscione R; Goretti E; Cattabriga I; Grillone G; Bacchi-Reggiani L; Pacini D
J Cardiothorac Vasc Anesth; 2005 Aug; 19(4):440-5. PubMed ID: 16085247
[TBL] [Abstract][Full Text] [Related]
13. Immunoglobulin therapy of neonatal group B streptococcal infections: an overview.
Fischer GW
Pediatr Infect Dis J; 1988 May; 7(5 Suppl):S13-6. PubMed ID: 3041355
[TBL] [Abstract][Full Text] [Related]
14. Human immunoglobulins for intravenous use: comparison of available preparations for group B streptococcal antibody levels, opsonic activity, and efficacy in animal models.
Givner LB
Pediatrics; 1990 Dec; 86(6):955-62. PubMed ID: 2123536
[TBL] [Abstract][Full Text] [Related]
15. Effect of intravenous immunoglobulin G on the deposition of immunoglobulin G and C3 onto type III group B streptococcus and Escherichia coli K1.
Lassiter HA; Robinson TW; Brown MS; Hall DC; Hill HR; Christensen RD
J Perinatol; 1996; 16(5):346-51. PubMed ID: 8915932
[TBL] [Abstract][Full Text] [Related]
16. Meta-analyses of the effectiveness of intravenous immune globulin for prevention and treatment of neonatal sepsis.
Jenson HB; Pollock BH
Pediatrics; 1997 Feb; 99(2):E2. PubMed ID: 9099759
[TBL] [Abstract][Full Text] [Related]
17. A multicenter, randomized, double-blind, placebo-controlled trial of high-dose intravenous immunoglobulin for oral corticosteroid-dependent asthma.
Kishiyama JL; Valacer D; Cunningham-Rundles C; Sperber K; Richmond GW; Abramson S; Glovsky M; Stiehm R; Stocks J; Rosenberg L; Shames RS; Corn B; Shearer WT; Bacot B; DiMaio M; Tonetta S; Adelman DC
Clin Immunol; 1999 May; 91(2):126-33. PubMed ID: 10227804
[TBL] [Abstract][Full Text] [Related]
18. The use of intravenous immunoglobulin (IVIG) to prevent infections in bronchopulmonary dysplasia: report of a pilot study.
Malik S; Giacoia GP; West K
J Perinatol; 1991 Sep; 11(3):239-44. PubMed ID: 1919822
[TBL] [Abstract][Full Text] [Related]
19. Preterm infants with low immunoglobulin G levels have increased risk of neonatal sepsis but do not benefit from prophylactic immunoglobulin G.
Sandberg K; Fasth A; Berger A; Eibl M; Isacson K; Lischka A; Pollak A; Tessin I; Thiringer K
J Pediatr; 2000 Nov; 137(5):623-8. PubMed ID: 11060526
[TBL] [Abstract][Full Text] [Related]
20. Intravenous immunoglobulin: new clinical applications.
Steele RW; Burks AW; Williams LW
Ann Allergy; 1988 Feb; 60(2):89-94. PubMed ID: 2829663
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
